Brief: Shilpa Medicare Says USFDA Inspection At Shilpa Pharma Unit-2 Closed With Zero Observations
14/03/2025 13:53
March 14 (Reuters) - Shilpa Medicare Ltd SHME.NS: USFDA INSPECTION AT SHILPA PHARMA UNIT-2 CLOSED WITH ZERO OBSERVATIONS Source text: ID:nBSE3MDjcb Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026